Table 5.
National prevalence and adjusted odds of cost-related non-adherence among respondents to the 2014 Commonwealth Fund International Health Policy Survey of Older Adults, stratified by age
| All ages (55+) |
Ages 55 to 64 |
Ages 65+ |
||||
|---|---|---|---|---|---|---|
| Country | CRNA % | Adjusted OR (95% CI) | CRNA % | Adjusted OR (95% CI) | CRNA % | Adjusted OR (95% CI) |
| Australia | 6.8 | 2.17 (1.28 to 3.67) | 8.2 | 2.07 (1.00 to 4.31) | 4.4 | 2.31 (1.09 to 4.88) |
| Canada | 8.3 | 2.76 (1.66 to 4.59) | 11.6 | 3.18 (1.57 to 6.46) | 5.3 | 2.25 (1.08 to 4.69) |
| France | 1.6 | 0.47 (0.23 to 0.94) | 3.4 | 0.69 (0.28 to 1.72) | 1.5 | 0.23 (0.07 to 0.76) |
| Germany | 3.7 | 0.99 (0.52 to 1.91) | 3.8 | 0.61 (0.23 to 1.67) | 4.2 | 1.46 (0.61 to 3.49) |
| Netherlands | 4.0 | 1.18 (0.62 to 2.23) | 4.0 | 1.20 (0.51 to 2.88) | 2.9 | 1.17 (0.46 to 2.99) |
| New Zealand | 4.8 | 1.68 (0.87 to 3.23) | 7.5 | 1.83 (0.76 to 4.44) | 3.4 | 1.48 (0.56 to 3.49) |
| Norway | 2.4 | 0.66 (0.33 to 1.31) | 3.8 | 0.63 (0.24 to 1.68) | 1.9 | 0.68 (0.26 to 1.82) |
| Sweden | 2.4 | 0.80 (0.47 to 1.37) | 3.9 | 0.94 (0.45 to 1.97) | 1.8 | 0.68 (0.33 to 1.44) |
| Switzerland | 2.9 | 0.86 (0.48 to 1.56) | 2.9 | 0.74 (0.32 to 1.75) | 2.5 | 0.98 (0.43 to 2.26) |
| UK | 3.1 | Reference | 4.4 | Reference | 2.3 | Reference |
| USA | 16.8 | 6.09 (3.60 to 10.20) | 22.2 | 5.45 (2.65 to 11.21) | 12.0 | 7.19 (3.43 to 15.07) |
| Pseudo R2 | 0.148 | 0.149 | 0.112 | |||
Results reported in bold are significant at p=0.05. Adjusted ORs are from sample-weighted logistic regression models. Pooled age model controls for age group, sex, health status and household income (not shown). Age-stratified models control for sex, health status and household income.
CRNA, cost-related non-adherence, sample-weighted prevalence.